Department of Pharmacology and Chemical Biology, Baylor College of Medicine, Houston, Texas 77030, United States.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, United States.
Biochemistry. 2023 Feb 7;62(3):564-579. doi: 10.1021/acs.biochem.2c00310. Epub 2022 Sep 21.
In the scope of targeted protein degradation (TPD), proteolysis-targeting chimeras (PROTACs), leveraging the ubiquitin-proteasome system, have been extensively studied. However, they are limited to the degradation of soluble and membrane proteins, excluding the aggregated and extracellular proteins and dysfunctional organelles. As an alternative protein degradation pathway, lysosomes serve as a feasible tool for accessing these untouched proteins and/or organelles by proteosomes. Here, we focus on reviewing the emerging lysosome-mediated TPD, such as AUTAC, ATTEC, AUTOTAC, LYTAC, and MoDE-A. Intracellular targets, such as soluble and aggregated proteins and organelles, can be degraded via the autophagy-lysosome pathway. Extracellular targets, such as membrane proteins, and secreted extracellular proteins can be degraded via the endosome-lysosome pathway. In addition, we summarize the mechanism and regulation of autophagy, available methods and assays for monitoring the autophagy process, and the recently developed chemical probes for perturbing the autophagy pathways.
在靶向蛋白降解(TPD)的范围内,利用泛素-蛋白酶体系统的蛋白水解靶向嵌合体(PROTACs)已经得到了广泛的研究。然而,它们仅限于降解可溶性和膜蛋白,而不能降解聚集的和细胞外的蛋白质以及功能失调的细胞器。作为一种替代的蛋白质降解途径,溶酶体可以作为一种可行的工具,通过蛋白酶体来获取这些未被触及的蛋白质和/或细胞器。在这里,我们重点回顾新兴的溶酶体介导的 TPD,如 AUTAC、ATTEC、AUTOTAC、LYTAC 和 MoDE-A。通过自噬-溶酶体途径可以降解细胞内的靶标,如可溶性和聚集的蛋白质和细胞器。通过内体-溶酶体途径可以降解细胞外的靶标,如膜蛋白和分泌的细胞外蛋白质。此外,我们总结了自噬的机制和调节、监测自噬过程的可用方法和检测,以及最近开发的用于扰乱自噬途径的化学探针。